We understand that in developing and commercializing therapeutic and health technologies, every decision is consequential. As life sciences innovation advances and complexity grows, teams need to move beyond reactive analysis toward anticipation.
With that context, we begin our next chapter today as Insira℠, an independent company redefining how life sciences and healthcare teams anticipate what’s next. Insira builds on the trusted products and brands our customers know today, including Cortellis and DRG, and the data and deep domain expertise behind them. With increased capital and focus, we can take those strengths further, evolving our products, bringing our intelligence together in new ways to help customers anticipate what matters most and stay ahead of the question.
Our ambition is to deliver data before demand and insights beyond the obvious, directly into the flow of work. Whether customers work within our platforms, enterprise solutions or their own tools, we are advancing anticipatory intelligence to help them prepare for the next decision.
A Trusted Foundation. An Unshakeable Edge.
With 88% of drugs entering Phase 1 failing to reach the market, according to the 2025 CMR International Pharmaceutical R&D Factbook, and R&D costs continuing to climb, the stakes for life sciences innovation have never been higher.
Our customers have long relied on our trusted data and leading intelligence platforms, including Cortellis, DRG and Dialog, to navigate the lifecycle of their products. As Insira, we are building on this foundation, combining proprietary data, deep domain expertise and evolving AI capabilities to give life sciences teams an unshakeable edge.
By integrating next-generation AI into the solutions our customers rely on every day, Insira is helping customers move towards more confident and informed decisions.
The Shift to True Anticipation
Anticipating what comes next means more than finding answers faster. It means data that’s ready before you ask, insights that go beyond the obvious, and expertise to help you decide what’s next. By bringing together trusted intelligence, deep domain expertise and AI, we are helping our customers uncover emerging trends, anticipate evolving needs, and make more informed decisions through every stage of the drug and device lifecycle.
Making Success a Predictable Reality
Our mission is to double success rates in treatment innovation, again and again. By turning reactive analysis into proactive foresight, we are working toward a future where the success of therapeutic and health technologies is a predictable reality.
This is the ambition that will guide Insira’s next chapter and the lasting impact we strive to make for patients worldwide.